M Fisher Selected Research

LOE 908

9/2000	Broad-spectrum cation channel inhibition by LOE 908 MS reduces infarct volume in vivo and postmortem in focal cerebral ischemia in the rat.
1/2000	Broad-spectrum cation channel inhibition by LOE 908 MS reduces infarct volume in vivo and postmortem in focal cerebral ischemia in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Fisher Research Topics

Disease

13	Infections 04/2018 - 01/2000
10	Stroke (Strokes) 02/2017 - 11/2000
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2006 - 01/2000
7	Ischemic Stroke 02/2017 - 04/2000
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 03/2007
6	Infarction (Infarctions) 03/2004 - 01/2000
6	Ischemia 08/2001 - 01/2000
5	Type 2 Diabetes Mellitus (MODY) 04/2015 - 01/2007
5	Neoplasms (Cancer) 03/2014 - 07/2000
3	Disease Progression 01/2018 - 11/2001
3	Necrosis 11/2014 - 04/2000
3	Myocardial Infarction 09/2009 - 04/2005
3	Brain Ischemia (Cerebral Ischemia) 09/2003 - 01/2000
2	Ochronosis 10/2018 - 01/2018
2	Alkaptonuria 10/2018 - 01/2018
2	Vascular Diseases (Vascular Disease) 03/2017 - 08/2010
2	Glucose Intolerance 10/2015 - 01/2007
2	Hepatitis C 03/2013 - 09/2007
2	Feeding and Eating Disorders (Eating Disorder) 12/2012 - 03/2001
2	Hemorrhage 09/2011 - 05/2010
2	Hepatitis B 07/2009 - 07/2001
2	Transient Ischemic Attack 01/2009 - 01/2009
2	Weight Loss (Weight Reduction) 07/2008 - 03/2001
2	HIV Infections (HIV Infection) 01/2008 - 06/2002
2	Cerebral Infarction 09/2000 - 01/2000
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2018
1	Alkaptonuric ochronosis 01/2018
1	Pulmonary Hypertension 03/2017
1	Hypertension (High Blood Pressure) 03/2017
1	Cardiomyopathies (Cardiomyopathy) 03/2017
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2014
1	Flea Infestations 01/2014
1	Body Weight (Weight, Body) 12/2012
1	Proteinuria 10/2012
1	Prostatic Neoplasms (Prostate Cancer) 09/2011
1	Peripheral Arterial Disease 09/2011

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 07/2010 - 09/2000
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2011 - 05/2008
3	Insulin (Novolin)FDA Link 01/2020 - 04/2005
3	RNA (Ribonucleic Acid)IBA 01/2012 - 03/2007
3	Pharmaceutical PreparationsIBA 01/2008 - 01/2000
3	triphenyltetrazoliumIBA 09/2000 - 01/2000
2	nitisinone (Orfadin)FDA Link 10/2018 - 01/2018
2	Homogentisic AcidIBA 10/2018 - 01/2018
2	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2017 - 11/2002
2	Tenofovir (Viread)FDA Link 01/2016 - 07/2009
2	Antiviral Agents (Antivirals)IBA 04/2014 - 02/2010
2	InterferonsIBA 03/2014 - 02/2009
2	Ribavirin (Virazole)FDA LinkGeneric 03/2013 - 09/2007
2	Interferon-alpha (Interferon Alfa)IBA 03/2013 - 09/2007
2	Proteins (Proteins, Gene)FDA Link 10/2012 - 05/2001
2	Clopidogrel (Plavix)FDA Link 09/2011 - 05/2010
2	insulin receptor-related receptor (IRR)IBA 02/2010 - 03/2007
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2009 - 05/2008
2	ChemokinesIBA 02/2009 - 05/2001
2	terutrobanIBA 01/2009 - 01/2009
2	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2009 - 01/2009
2	Hypoglycemic Agents (Hypoglycemics)IBA 07/2008 - 01/2007
2	Neuroprotective AgentsIBA 09/2003 - 01/2000
2	salicylhydroxamic acid (SHAM)IBA 08/2001 - 04/2000
2	VaccinesIBA 07/2001 - 08/2000
2	LOE 908IBA 09/2000 - 01/2000
2	CationsIBA 09/2000 - 01/2000
2	N-Methylaspartate (NMDA)IBA 07/2000 - 01/2000
1	PolymersIBA 10/2018
1	Biological ProductsIBA 04/2018
1	danaparoid (Orgaran)FDA Link 02/2017
1	efavirenz (Sustiva)FDA Link 01/2016
1	Ritonavir (Norvir)FDA Link 01/2016
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2016
1	Emtricitabine (Emtriva)FDA Link 01/2016
1	lamivudine drug combination abacavir FDA Link 01/2016
1	RacivirIBA 01/2016
1	ArsenicIBA 10/2015
1	bisphenol AIBA 10/2015
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2015
1	Y 27632IBA 11/2014
1	CaspasesIBA 03/2014
1	Keratin-18 (Keratin 18)IBA 03/2014
1	spinosadIBA 01/2014
1	TabletsIBA 01/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2012
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 12/2012
1	AlbuminsIBA 10/2012
1	flubendazoleIBA 04/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2011
1	Dipyridamole (Persantine)FDA LinkGeneric 09/2011
1	EsapentIBA 09/2011

Therapy/Procedure

13	Therapeutics 01/2018 - 04/2000
9	Highly Active Antiretroviral Therapy (HAART) 01/2012 - 07/2001
3	Secondary Prevention 09/2011 - 01/2009
3	Sutures (Suture) 04/2007 - 09/2003
2	Art Therapy 02/2009 - 09/2005
2	Suture Techniques 01/2006 - 09/2003
2	Drug Therapy (Chemotherapy) 10/2004 - 02/2003
1	Transplantation 03/2017
1	Liver Transplantation 03/2017
1	Aftercare (After-Treatment) 03/2014